Mohammad Sarafroz
Overview
Explore the profile of Mohammad Sarafroz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
17
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Al Khzem A, Shoaib T, Mukhtar R, Alturki M, Gomaa M, Hussein D, et al.
Pharmaceuticals (Basel)
. 2025 Feb;
18(2).
PMID: 40005988
infects approximately half of the global population, causing chronic gastritis, peptic ulcers, and gastric cancer, a leading cause of cancer mortality. While current therapies face challenges from rising antibiotic resistance,...
2.
Gomaa M, Alturki M, Tawfeeq N, Hussein D, Pottoo F, Al Khzem A, et al.
Pharmaceutics
. 2025 Jan;
16(12.
PMID: 39771585
Glucagon-like peptide-1 (GLP-1) receptor is currently one of the most explored targets exploited for the management of diabetes and obesity, with many aspects of its mechanisms behind cardiovascular protection yet...
3.
Al Khzem A, Gomaa M, Alturki M, Tawfeeq N, Sarafroz M, Alonaizi S, et al.
Int J Mol Sci
. 2024 Nov;
25(22).
PMID: 39596504
Cancer ranks among the primary contributors to global mortality. In 2022, the global incidence of new cancer cases reached about 20 million, while the number of cancer-related fatalities reached 9.7...
4.
Dakne G, Taleuzzaman M, Sarafroz M, Yadav P, Khatoon Y, Haque Z, et al.
Recent Adv Antiinfect Drug Discov
. 2023 Feb;
18(3):239-253.
PMID: 36815640
Background: High-performance thin-layer chromatography (HPTLC) was developed and validated for the determination of aloe-emodin in accordance with ICH guidelines. In addition, a novel RP-UHPLC method was developed, and both methods...
5.
Amir M, Zafar A, Ahmad R, Ahmad W, Sarafroz M, Khalid M, et al.
Plants (Basel)
. 2022 Mar;
11(5).
PMID: 35270176
The increase in the use of herbal medicines has led to the implementation of more stern regulations in terms of quality variation and standardization. As medicinal plants are prone to...
6.
Ahmad W, Amir M, Ahmad A, Ali A, Ali A, Wahab S, et al.
Plants (Basel)
. 2021 Dec;
10(12).
PMID: 34961044
For many years, () has been used medicinally and as a dietary supplement. Despite this, there are minimal research data on phytochemical properties and pharmacological effects. This study aimed to...
7.
Verma R, Vyas P, Kaur J, Noushad Javed M, Sarafroz M, Ahmad M, et al.
CNS Neurol Disord Drug Targets
. 2021 Sep;
21(6):479-491.
PMID: 34477535
Background And Objective: Hearing loss is a common audio-vestibular-related neurosensory disability of inner ears, in which patients exhibit clinical symptoms of dizziness, gait unsteadiness, and oscillopsia, at an initial stage....
8.
Husain A, Naseer M, Sarafroz M
Acta Pol Pharm
. 2009 Sep;
66(2):135-40.
PMID: 19719046
In the present investigation, a series of 3,6-disubstituted-1,2,4-triazolo-1,3,4-thiadiazole derivatives (6a-t) were synthesized and evaluated for their anticonvulsant activity and neurotoxicity. The structures of synthesized compounds were confirmed on the basis...
9.
Husain A, Sarafroz M, Ahuja P
Acta Pol Pharm
. 2008 Dec;
65(5):527-34.
PMID: 19051598
In the present investigation, two novel series of 2-[3-(4-chlorophenyl)propan-3-one]-5-(substituted phenyl)-1,3,4-oxadiazole and 2-[3-(4-ethylphenyl)propan-3-one]-5-(substituted phenyl)-1,3,4-oxadiazole were synthesized and tested for their antiinflammatory, analgesic, ulcerogenic and antibacterial actions. A fair number of compounds...